Serum Amyloid Biomarkers, Tau Protein and YKL-40 Utility in Detection, Differential Diagnosing, and Monitoring of Dementia.

Wilczynska, Karolina; Maciejczyk, Mateusz; Zalewska, Anna; Waszkiewicz, Napoleon

Wilczynska, Karolina; Maciejczyk, Mateusz; Zalewska, Anna; Waszkiewicz, Napoleon.

Afiliación

Wilczynska K; Department of Psychiatry, Medical University of Bialystok, Bialystok, Poland.
Maciejczyk M; Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Bialystok, Poland.
Zalewska A; Experimental Dentistry Laboratory, Medical University of Bialystok, Bialystok, Poland.
Waszkiewicz N; Department of Psychiatry, Medical University of Bialystok, Bialystok, Poland.

Front Psychiatry ; 12: 725511, 2021.

Article en En | MEDLINE | ID: mdl-34589009

Palabras clave

Alzheimer's dementia (AD); YKL-40 (chitinase 3-like 1); amyloid beta; mixed dementia; serum; tau protein; vascular dementia (VaD)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Aspecto: Patient_preference Idioma: En Revista: Front Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google